Background/Aims: Our previous studies have indicated that a novel endothelin receptor antagonist CPU0213 effectively normalized renal function in diabetic nephropathy. However, the molecular mechanisms mediating the nephroprotective role of CPU0213 remain unknown.
Inhibition of CPU0213, a Dual Endothelin

Introduction
Diabetic nephropathy is one of the most serious complications of diabetes mellitus due to its high morbidity and mortality. Increased systemic endothelin-1 (ET-1) levels are linked to a decline in renal function, the development of interstitial fibrosis, proteinuria, cardiomyopathy and glomerulosclerosis in patients suffering from renal disease [1] [2] [3] [4] . CPU0213 is a novel endothelin receptor antagonist discovered by screening newly synthetic compounds in our laboratory. We have demonstrated that CPU0213 effectively normalized renal function in diabetic nephropathy [5] [6] [7] . However, the mechanisms by which CPU0213 inhibited endothelial system to improve renal function in diabetic nephropathy are not understood.
Although vascular and glomerular injuries have been considered as the main features of diabetic kidney diseases, tubular atrophy also plays a major role in the disease [8] . It has been demonstrated that tubular functional and morphological changes precede the onset of microalbuminuria in early diabetic nephropathy [9] . Hyperglycemia triggers the generation of reactive oxygen species (ROS), which are considered to be important mediators for apoptosis in tubular epithelial cells [10, 11] . Furthermore, the renal source of ROS mostly comes from NADPH oxidase (Nox), and inhibition of Nox by apocynin, a Nox inhibitor, has been proven to protect effectively against diabetic nephropathy [12] . Nox isoform Nox4 is most abundant in the tubule cells and its upregulation indicates renal tubular damage in diabetic nephropathy [13] .
Given more ET-1 produced at the renal tubular epithelial cells than any other cell type [14, 15] , we hypothesis that CPU0213 inhibits apoptosis in renal tubular epithelial cells. To test this hypothesis, the present study used human renal tubular epithelial cell line (HK-2) to test the role of CPU0213 on apoptosis by Western blot analysis and flow cytometer. Then, we went on to reveal that Nox4-dependent superoxide (O 2 -. ) production mediated the protection of CPU0213 on apoptosis. Lastly, we demonstrated the inhibitory role of CPU0213 on endothelin A (ET A R) and B receptors (ET B R) which is likely to mediate the regulation of Nox4.
Materials and Methods
Cells culture and reagents
Stable HK-2 cell lines are derived from human kidney tubule cells. The cells were plated on 50 cm 2 culture flask and incubated in 5% CO 2 at 37℃, expended in DMEM/F12 (HyClone) supplemented with 10% FBS (Gibco) and 2% antibiotics (Hyclone). The medium was replaced once or twice each week until the cells grew to 80% confluence, and exponential phase cells can be distributed randomly into 4 groups: control(Ctrl), high-glucose(HG, 30 mM) alone, and HG incubated cells intervened with either CPU0213 (10 -5 M) or apocynin (Apo,10 -5 M) for 48 hours, respectively. Dosage of CPU0213 is consistent with our previous report [5] , and MTT assay in current study (not shown) also showed that HG decreased cell viability, which more significantly increased due to the treatment with CPU0213 in 10 M and 10 -6 M. CPU0213, purity > 98%, a dual endothelin receptor antagonist was synthesized and provided by the Department of Medicinal Chemistry of China Pharmaceutical University, Nanjing, China. Apocynin was purchased from Sigma-Aldrich Corporate, St. Louis, MO, Lot S43156-327.
Western blot analysis
Western blot analysis was performed as we described previously [16] . In brief, proteins from the HK-2 cells were extracted using RIPA (BU Technology CO, LTD) and the protein concentration was tested by BCA protein quantitative kit (BU). After boiling for 5 min at 95°C in a 5× loading buffer (BU), 30 μg of total proteins were separated by 10% or 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) at 80 V for 30 min and then 100V for 1 h. The proteins were then electrophoretically transferred to polyvinylidene fluoride membranes (PDVF membrane, Bio-Rad) at 80A for 1 h. The membranes were blocked with 5% non-fat milk (5% w/v) in Tris-buffered saline with Tween 20 for 1 h. After washing, the membranes were probed with 1:300 dilution of first antibodies (β-actin, Bax, Bcl-2, Nox4: Wuha Boster Biological Technology) overnight at 4°C. After 3 times of wash, the membranes were incubated with Goat Anti-Mouse IgG or Goat Anti-Rabbit IgG (1:3500, Wuha Boster Biological Technology) for 1.5 h. The blot was detected by chemiluminescent detection systems with LumiGlo and Peroxide (1:1, BU). Densitometric analysis of the images was performed with ImageJ software (NIH, Littleton, CO, USA).
Apoptosis assay by flow cytometry
Apoptosis of HK-2 cells were detected using an Annexin V-FITC Apoptosis Detection Kit (Vazyme Biotech) according to the manufacturer's instructions. Cells were trypsinized and collected by centrifugation at 1000 r/min for 5 min at room temperature. The cells were washed twice in cold (4°C) phosphate buffer saline (PBS) and then subjected to another centrifugation, and then the cells were resuspended in 100 µL Binding Buffer (5 × 10 5 cells/100 µL). After 5 µL Annexin V-FITC and 5 µL PI Staining Solution treatment, the cells were detected by a flow cytometer (BD Accuri) within 1 hour. the results were analyzed using FlowJo 7.6 software and the percentage of cells to total cells was calculated as the rate of apoptotic cells.
Measurement of O 2
-. production Total O 2 -production by HK-2 cells was measured using the fluorescent probe dihydroethidium (DHE, Sigma, CAS 104821-25-2). DHE entered the cells through the cell membranes, it is oxidized by intracellular O 2 -, and then incorporated into the chromosomal DNA to produce red fluorescence, intensity of the red fluorescence can determine changes in intracellular O 2 -.
level. The HK-2 cells were cultured in 6-well plates in 5% CO 2 -95% O 2 at 37°C. After treatment, each well was washed twice with 2 mL PBS, meanwhile DHE was diluted with serum free-medium to a final concentration of 10 μM. 2mL dilution was evenly added to each well, and incubated 30 min in 5% CO 2 at 37°C without light. After the incubation, HK-2 cells were washed 3 times with 1-2 mL PBS, red fluorescence images were captured by fluorescence microscopy. The intensity of fluorescence was analyzed and processed by ImageJ software and the ratio of fluorescence intensity to that at basal level was quantified to show O 2 -level.
RNA interference of Nox4
Nox4 siRNA were purchased from Santa Cruz (sc-41586). A scrambled small RNA (5′-AAUUCUCCGAACGUGUCACGU-3′) was also confirmed no silencing of genes and used as a negative control in the present study. Transfection of Nox4 siRNA was performed using the GeneTran™ III(BIOMIGA) according to the manufacturer's instructions, and the efficiency of siRNA to silence Nox4 genes were confirmed with Western blot analysis.
Statistical analysis
Data are presented as the mean ± SE. Significant differences between and within multiple groups were examined using analysis of variance for repeated measures, followed by Duncan's multiple-range test. Student's t test was used to detect significant differences between two groups. p < 0.05 was considered statistically significant.
Results
CPU0213 reversed the protein level of Bax and Bcl-2 under high glucose
Bcl-2 extra large (Bax) and B-cell lymphoma 2 (Bcl-2) are prototypical members of a large family of Bcl-2-like proteins that play a key role in regulating programmed cell death in many cell types [17] . To examine whether CPU0213 inhibited apoptosis in HK-2 cells, the protein levels of Bax and Bcl-2 were tested by western blot analysis. As showed in Fig. 1A , the incubation of HK-2 cells with high glucose significantly enhanced the level of Bax protein, which was decreased by the pretreatment with CPU0213. Conversely, Fig. 1B showed that the expression of Bcl-2 protein was markedly decreased in high glucose-treated HK-2 cells compared with control, which increased after the intervention by CPU0213. In addition, the abnormal expression of Bax and Bcl-2 were reversed by NADPH oxidase inhibitor apocynin under high glucose stimulation (Fig. 1C, D) , suggesting that NADPH oxidase may be involved in the inhibition of CPU0213 on apoptosis.
CPU0213 inhibited Annexin V-FITC bound cell percentage under high glucose
To confirm the role of CPU0213 on apoptosis, apoptotic cells were detected by using Annexin V/PI double staining followed by flow cytometric examination ( Fig. 2A) . We observed that the percentage of HK-2 cells that showed Annexin V-FITC binding was only 0.05% (Fig. 2B) . However, high glucose led to Annexin V-FITC bound cell percentage of 32% after 48 hours. When HK-2 cells were pretreated with CPU0213, the rate of apoptosis was markedly suppressed by 31.2%, which confirmed the inhibitory role of CPU0213 on apoptosis. In addition, it was found that high glucose-induced apoptosis was significantly inhibited by NADPH oxidase inhibitor apocynin (Fig. 2C) .
CPU0213 decreased O 2
-. production under high glucose O 2 -. oxidizes DHE to produce a strong red fluorescence, thus DHE is widely used for intracellular O 2 -. production. As showed in Fig. 3A and 3B, CPU0213 significantly blocked the increase in intracellular red fluorescence induced by high glucose compared with control. The inhibitory effects of apocynin on O 2 -. production were also observed, suggesting that O 2 -.
production during high glucose stimulation was mainly derived from NADPH oxidase (Fig.  3C) . 
Nox4 protein was inhibited by CPU0213 under high glucose
To gain further insights into the molecular mechanisms underlying O 2 -. reduction by CPU0213, the possible involvement of Nox4 was examined. Here, we found that Nox4 protein was dramatically increased in HK-2 cells incubated with high glucose, which was inhibited by CPU0213 (Fig. 4A) . However, there was no significant difference in Nox1 and Nox2 protein expression after the treatment with CPU0213 (not shown). As expected, the expression of Nox4 protein was significantly inhibited by NADPH oxidase inhibitor apocynin (Fig. 4B) . 
Nox4 deficiency inhibited the apoptosis in HK-2 cells
To eluci date the role of Nox4 protein on apoptosis in HK-2 cells, we next examined whether HK-2 cells lacking Nox4 gene exhibit apoptosis. Nox4 siRNA was transfected into HK-2 cells and the apoptosis was observed. We demonstrated that Nox4 siRNA inhibited the protein expression of Nox4 by 88.5% (not shown). As showed in Fig. 5A and 5B, Nox4 siRNA resulted in a significant increase in the level of Bax protein as well as the decrease of Bcl-2 in under high glucose stimulation. In addition, the Annexin V-FITC bound cell percentage was inhibited in HK-2 cells with silencing of Nox4 (Fig. 5C ). O 2 -. level induced by high glucose was significantly inhibited after Nox4 siRNA transfection, which confirmed the transfection efficacy of Nox4 siRNA in HK-2 cells (Fig. 5D ).
CPU0213 inhibited the ET A R and ET B R receptor
Given that ET A R and/or ET B R mediate Nox-dependent O 2 -. generation, we finally examined whether ET A R and ET B R were inhibited by CPU0213 in HK-2 cells incubated with high glucose. As showed in Fig. 6A , the protein level of ET A R dramatically decreased in HK-2 cells under high glucose treatment, which was inhibited by CPU0213. Similarly, high glucoseinduced protein expression of ET B R was inhibited by CPU0213 (Fig. 6B) . Taken together, these results indicated that CPU0213 inhibited ET-1 receptor, consequently resulting in Nox4 deactivation.
Discussion
In the present study, we provided novel evidences that apoptosis in HK-2 cells are triggered by high glucose. Furthermore, this Nox4-dependenet O 2 -. production is critical for the apoptosis of HK-2 cells in high glucose. Importantly, we demonstrated that dual endothelin receptor antagonist CPU0213 has an anti-apoptosis role through Nox4-dependent O 2 -. production in HK-2 cells. Diabetes induces early signs of tubular dysfunction, and diabetic kidneys are particularly prone to acute tubular necrosis in diverse clinical situations, such as post-cardiac surgery. High glucose is an independent risk factor for acute tubular necrosis associated with apoptosis in renal tubular epithelial cells [18] . In the present study, we also demonstrated abnormal expression of apoptosis markers in HK-2 cells under high glucose stimulations. CPU0213 is a novel endothelin receptor antagonist, which is effective in relieving the acute renal failure by septic shock, isoproterenol or diabetes [5] [6] [7] . However, a key mechanism of CPU0213 in neproprotection has not been determined. In the present study, we determined the critical role of CPU0213 in ameliorating the apoptosis in HK-2 cells, which strongly indicate that anti-apoptosis is a critical mechanism for neproprotective role of CPU0213 during diabetic lesions. It also confirms that the ET-1 system plays an important role on diabetic tubular dysfunction associated with progressive tubulointerstitial fibrosis. Excessive ET-1 can lead to activation of NOS and protein kinase C, ultimately resulting in a reduction of efflux transport in the proximal tubule exposed to nephrotoxicants [14, 19] . Moreover, the findings from clinical investigations show that ET-1 is present the plasma level of in patients with end stage renal insufficiency and high level of ET-1 correlated with the extent of renal dysfunction in sepsis [20] . Combing with our current findings, it was believed that ET-1 system regulates apoptosis of renal tubular epithelial cells associated with progressive tubulointerstitial fibrosis in diabetic nephrology.
To further test how CPU0213 inhibited apoptosis in HK-2 cells, we examined the role of CPU0213 on redox signaling. ROS has emerged as a causal factor in the progression of diabetic nephrology, where ROS are produced mainly by tubular cells, mesangial cells, podocytes and fibroblasts [21, 22] . It was found that CPU0213 indeed inhibited the production of O 2 -. in HK-2 cells, which suggests an anti-oxidative role of CPU0213 in high glucose. We previously revealed that upregulation of the ET-1 system was associated with O 2 -. in streptozotocininduced diabetic cardiomyopathy [23, 24] . Inversely, O 2 -. stimulates the production of ET-1 by glomeruli and other renal cells in high glucose [25, 26] . Thus, O 2 -. as a downstream event exerts a positive feedback regulatory action on the ET-1 production in diabetic nephrology, which is obviously blocked by CPU0213 in HK-2 cells.
In current study, we observed that high glucose-induced O 2 -. production was prevented by Nox inhibitor apocynin, which suggests that O 2 -. induced by high glucose is primarily produced by Nox. It confirms some reports that inhibition of Nox is protective in several experimental models of acute and chronic kidney diseases [27] [28] [29] . It was demonstrated that Nox isoforms 1, 2 and 4 are expressed in tubular cells [30] . We further explored the Nox isoform mediating the anti-oxidative role of CPU0213 in HK-2 cells. The current study demonstrated that the upregulation of Nox4 was paralleled with O 2 -. overproduction and protein expression of Nox4 is inhibited by CPU0213 upon high glucose stimulations. Moreover, it was shown that Nox4 gene deletion reduced apoptotic HK-2 cells, which mimicked the effects of CPU0213 on apoptosis upon high glucose. This for the first time links Nox4 and apoptosis in HK-2 cells, suggesting that Nox4-dependent O 2 -. production is involved in apoptosis in HK-2 cells during hyperglycemia. In addition, the current data (not shown) indicated that there was no significant difference in the protein expression of Nox1 and Nox2 after the treatment with CPU0213. Thus, Nox4 alone mediates the anti-oxidative role of CPU0213 in HK-2 cells incubated with high glucose. It further suggested that Nox4 is the main source of ROS in response to high glucose [31] , which may help develop novel effective therapeutic target to target Nox4 for treatment of diabetic nephrology. It was reported that the inhibition of Nox4 prevented uric acid-induced cell injury by suppressing phosphorylation of P38/ERK in HK-2 cells [13] . Thus, P38/ERK activation likely connects Nox4 with HK-2 cell apoptosis upon high glucose stimulations.
Finally, we further explored the ET receptors mediating Nox4 inhibition by CPU0213 in HK-2 cells upon high glucose stimulations. The potency of CPU0213 to block the ET A R and ET B R receptors is more potent than that of bosentan [32] . Here, we demonstrated that the protein expression of both ET A R and ET B R were inhibited by CPU0213 in HK-2 cells. Thus, it is likely that dual ET A/B R blockers are likely more effective on Nox suppression than selective ET A R blockers. A previous study has shown that ET-1 significantly enhanced ROS generation and cell proliferation, which were prevented by selective ET B R blockers [33] . However, another study found that ET-1 stimulates ET A R-mediated Nox-dependent ROS generation in penile arteries [34] . Thus, Nox activation may respond to different ET receptors in different cell types and models. The anti-oxidative effect of CPU0213 stems from the ET A R and ET B R blocking effects in HK-2 cells will be further studied in future.
In conclusion, we demonstrated that high glucose leads to the production of Nox4-dependent O 2 -. , consequently triggering the apoptosis in HK-2 cells, which is involved in the pathology of diabetic nephropathy. The apoptosis is suppressed by a dual ET A/B R blocker CPU0213 via Nox4-dependent O 2 -. production, which address the nephroprotective role of CPU0213 and strengthens CPU0213 as a potential drug in relieving diabetic nephropathy. 
